We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · June 27, 2022

TMB, HLA-ABC Status, and Lymphocyte Infiltration of Paired Primary and Metastatic Lesions of Patients With Ipilimumab-Treated Melanoma

Journal for immunotherapy of cancer


Additional Info

Journal for immunotherapy of cancer
Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression whereas tumor mutational load is similar and correlates with clinical outcome
J Immunother Cancer 2022 May 01;10(5)e004329, MAJ Gorris, LL van der Woude, LI Kroeze, K Bol, K Verrijp, AL Amir, J Meek, J Textor, CG Figdor, IJM de Vries

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading